Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2009
01/08/2009WO2009005730A1 Transgenic animal models of parkinson's disease
01/08/2009WO2009005715A1 Methods for a predictive diagnostic test for tamoxifen
01/08/2009WO2009005701A1 Biosensors and methods of preparing same
01/08/2009WO2009005651A2 Complement-mediated thrombophilic assay
01/08/2009WO2009005615A1 Methods and compositions for identifying agents that inhibit an ns4b-mediated neoplastic cellular phenotype of hcv infected cells
01/08/2009WO2009005567A1 Chip assay having improved efficiency
01/08/2009WO2009005536A2 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
01/08/2009WO2009005231A1 Methods for quantitatively determining endotoxin
01/08/2009WO2009005186A1 Spectral sensor for surface-enhanced raman scattering
01/08/2009WO2009005155A1 Method for maintaining proliferation/differentiation ability of mesenchymal stem cell
01/08/2009WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach
01/08/2009WO2009005117A1 Method and apparatus for detection of biomicromolecule
01/08/2009WO2009005112A1 Method for analysis of metal sample
01/08/2009WO2009005111A1 Method for analysis of metallic material
01/08/2009WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710
01/08/2009WO2009004984A1 Agglutination image automatic judging method by mt system, device, program, and recording medium
01/08/2009WO2009004822A1 ANTI-Muc17 ANTIBODY
01/08/2009WO2009004588A1 Porous biological assay substrate and method for producing such substrate
01/08/2009WO2009004576A1 Diagnostic markers for detecting prostate cancer
01/08/2009WO2009004538A1 Microelectronic sensor device for examinations in a carrier
01/08/2009WO2009004380A1 Method and use of circulating levels of endocannabinoid ligands for the determination of patient in need and/or suitable for cb1r antagonist drug treatment as well as method for inducing weight loss/maintenance/gain
01/08/2009WO2009004340A2 Identification of ectopic pregnancies
01/08/2009WO2009004315A1 Isolated peptides and uses thereof
01/08/2009WO2009004247A2 Tace inhibitors in the treatment of acne
01/08/2009WO2009004216A2 Method for a vehicle fuel circuit
01/08/2009WO2009004189A2 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
01/08/2009WO2009004142A2 Method for fixing compounds comprising peptide bonds, such as proteins, to a microsystem, and microsystem incorporating these compounds
01/08/2009WO2009004068A2 Androgen-dependent 1-f-aromatase reporter gene
01/08/2009WO2009004056A1 Method for the multiplex serological diagnosis in vitro of spirochete infections
01/08/2009WO2009004041A2 Colorimetric assay for the visual detection of primary and secondary amines
01/08/2009WO2009004017A1 Method for the production of an analytical element
01/08/2009WO2009003952A2 Column and method for preparing a biological sample for protein profiling
01/08/2009WO2009003856A1 Method for the production of a microfluidic system on a polymer surface
01/08/2009WO2009003730A1 System and method for carrying out analysis
01/08/2009WO2009003706A2 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones
01/08/2009WO2009003691A1 Biosensor with laser-sealed capillary space and method of making
01/08/2009WO2009003497A1 Diagnostic composition and method for the detection of a trichinella infection
01/08/2009WO2009003493A2 Mhc multimers, methods for their generation, labeling and use
01/08/2009WO2009003492A1 Mhc multimers, methods for their generation, labeling and use
01/08/2009WO2009003441A2 Method for analysing the effect of a gaseous medium on a biological test system using an extracellular metabolisation system and device for carrying out said method
01/08/2009WO2009003291A1 Therapeutics and diagnostics for group a streptococci
01/08/2009WO2009003274A1 Susceptibility gene for inflammatory bowel disease
01/08/2009WO2009003273A1 Assessing tissue rejection
01/08/2009WO2009003208A1 Method for identifying and quantifying organic and biochemical substances
01/08/2009WO2008144700A3 Simian t-cell lymphotropic virus type 3 west african subtype d
01/08/2009WO2008142693A3 Regulation of myelination by nectin-like (necl) molecules
01/08/2009WO2008140581A3 Systems and methods for preparing and analyzing samples
01/08/2009WO2008138868A3 In vitro diagnosis and/or prognosis of cancer by the analysis of gtpase protein expression
01/08/2009WO2008138619A3 New ttv sequences for diagnosis, prevention and treatment of childhood leukaemia
01/08/2009WO2008138341A3 Methods for detection of 'pontiac' subgroups of legionella pneumophila serogroup 1
01/08/2009WO2008137552A3 Anti-rage antibodies and methods of use thereof
01/08/2009WO2008133729A3 Sequential analysis of biological samples with intermediate bleaching of fluorescence detector
01/08/2009WO2008133705A3 Assays and devices for identifying pathogens
01/08/2009WO2008131714A3 Method and arrangement for electrically contacting an object surrounded by a membrane, using an electrode
01/08/2009WO2008131047A3 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
01/08/2009WO2008131039A3 Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
01/08/2009WO2008127387A3 Modulators of protein phosphatase 2a holoenzyme
01/08/2009WO2008120202A3 Antibodies, methods and kits for diagnosing and treating melanoma
01/08/2009WO2008119567A3 Cross-species-specific cd3-epsilon binding domain
01/08/2009WO2008119565A3 Cross-species-specific binding domain
01/08/2009WO2008118202A3 Ret-based analyte detection
01/08/2009WO2008087035A3 Screening method for anti-diabetic compounds
01/08/2009WO2008082987A3 Analyte meter protectors and methods
01/08/2009WO2008073255A3 Spreading layer and humidity control layer for enhancing sensor performance
01/08/2009WO2008070311A3 Gene expression profiling of parkinson's disease
01/08/2009WO2008066996A3 A method to detect treponema pallidum immunological markers for the diagnosis of syphilis
01/08/2009WO2008016385A3 Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
01/08/2009WO2007141626A8 Circulating tumor cell assay
01/08/2009WO2007128004A3 Methods, compositions, and kits for detecting protein aggregates
01/08/2009WO2007117680A3 Methods and compositions for treating bacterial infection
01/08/2009WO2007089303A9 Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
01/08/2009WO2006104035A9 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene
01/08/2009WO2006072011A9 Methods, systems, and computer program products for developing and using predictive models for predicting a plurality of medical outcomes, for evaluating intervention strategies, and for simultaneously validating biomarker causality
01/08/2009US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use
01/08/2009US20090013417 Transgenic Animals for Assessing Drug Metabolism and Toxicity in Man
01/08/2009US20090013416 Pdes as modifiers of the igfr pathways and methods of use
01/08/2009US20090012714 Test of amino acid sequence constituting peptide using isotopic ratio
01/08/2009US20090012379 System and methods for processing analyte sensor data
01/08/2009US20090012270 Ox2 receptor homologs
01/08/2009US20090012267 Anti-hydroxylase antibodies and uses thereof
01/08/2009US20090012113 Administering rifaximin to the subject
01/08/2009US20090012093 Receptor Function Regulator
01/08/2009US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
01/08/2009US20090012061 A Method of Treating Cancer
01/08/2009US20090012042 Hydroxypropyl-Sulfobutyl-Beta-Cyclodextrin, the Preparation Method, the Analytical Method, and the Pharmacutical Application Thereof
01/08/2009US20090012026 Association Between the Tdoa Gene and Osteoarthritis
01/08/2009US20090012019 Methods and Compositions Related to TR4
01/08/2009US20090012017 Polypeptide Complex that Regulates Cell Cycle and Anergy
01/08/2009US20090012003 Polypeptides homologous to vegf and bmp1
01/08/2009US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
01/08/2009US20090011983 186 Human Secreted Proteins
01/08/2009US20090011958 Process for immobilizing orientation-controlled protein and process for arraying and immobilizing protein using the same
01/08/2009US20090011946 Use of Sequence Specific Polymers in Chemical Detection
01/08/2009US20090011943 High throughput genome sequencing on DNA arrays
01/08/2009US20090011521 Streptavidin surface acoustic wave immunosensor apparatus
01/08/2009US20090011520 Stable D-dimer liquid preparation
01/08/2009US20090011517 Sample Plate for Fluid Analysis in a Refinery Process
01/08/2009US20090011516 Methods and Assays for the Detection of Nitrogen Uptake by a Plant and Uses Thereof
01/08/2009US20090011515 Control of N-(Phosphonomethyl)Iminodiacetic Acid Conversion in Manufacture of Glyphosate
01/08/2009US20090011514 Dna Crosslinking for Primer Extension Assays